In Marfan’s syndrome, which is characterized by a fibrillin-1 gene mutation and excessive TGF-β leading to the development of aortic arch aneurysm and dissection, it is not clear if targeting the renin–angiotensin system can be beneficial [23]. Here, FBN1 is linked to Marfan syndrome.